What You Should Know:
- Valinor has launched with $13M in seed funding to tackle one of the pharmaceutical industry's most expensive challenges: clinical trial failure led by CRV and Harpoon Ventures.
- The company uses proprietary AI models trained on matched multi-omic samples and clinical outcomes to predict how specific patient populations will respond to new therapies. This "response-first" approach aims to drastically de-risk drug development by identifying responders
Read More
Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant
Subsense Raises $10M to Replace Brain Implants with Nasal Nanoparticles
What You Should Know:
- Subsense Inc. has raised an additional $10M, bringing its total funding to $27M, to develop a non-surgical brain-computer interface (BCI) that relies on engineered nanoparticles rather than implanted chips.
- Administered nasally to cross the blood-brain barrier, this technology aims to record and modulate brain activity with high precision without the risks associated with invasive surgery.
- The funding from Golden Falcon Capital
Read More
Accenture Invests in Ryght AI to Accelerate Clinical Trials with Agentic AI and Digital Twins
What You Should Know:
- Accenture has made a strategic investment in Ryght AI through its venture capital arm, aiming to modernize the sluggish clinical trial process. Ryght AI utilizes "agentic AI" and its proprietary AI Site Twin platform to create dynamic digital replicas of research sites, allowing pharmaceutical companies to optimize site selection and patient enrollment.
- The strategic collaboration seeks to remove the manual bottlenecks that delay life-saving therapies,
Read More
AngelEye Health Raises $9M Series C to Bring AI-Driven Insights to the NICU
What You Should Know:
- AngelEye Health secures $9M Series C funding round led by Mountain Group Partners, with strategic investment from Nationwide Children’s Hospital and a new debt facility from Live Oak Bank.
- The capital will fuel the commercial launch of AIVision, an AI-driven monitoring tool designed to provide earlier safety insights for neonatal care teams. Currently serving over 350 hospitals and 20% of NICU families in the U.S., AngelEye is pivoting from family
Read More
Paradigm Health Raises $78M & Acquires Flatiron Health’s Clinical Research Business
What You Should Know:
- Paradigm Health’s acquisition of Flatiron Health’s Clinical Research Business, coupled with a long-term strategic partnership, marks a structural shift in how oncology trials are conducted and how patients across the country gain access to them.
- The deal brings together the nation’s most extensive tech-enabled oncology research network with an AI-powered trial infrastructure, creating a unified ecosystem designed to expand trial capacity, reduce operational
Read More
Artera Hits $100M ARR and Secures $65M in Funding to Lead Agentic AI Adoption in Healthcare
What You Should Know:
- Artera, a leader in AI-powered patient communications secures $65M in growth investment led by Lead Edge Capital, following the milestone of reaching $100M in Contracted Annual Recurring Revenue (CARR) by the end of 2025.
- The funding accelerates the adoption of its Agentic AI solutions, which have already engaged over 200 million patients and demonstrated the ability to complete 94% of conversations without staff intervention. The company's decade of deep
Read More
Sober Sidekick’s Empathy Algorithm Achieves 88% Accuracy in Identifying High-Cost Risk, Attracts $7.6M Funding
What You Should Know:
- Empathy Health Technologies, the maker of the Sober Sidekick platform, has secured $7.6M in new growth funding, bringing its total to $11.4M.
- The investment will fuel the expansion of its value-based care partnerships with U.S. payers, leveraging its proprietary Empathy Algorithm to measure and prevent relapse in real-time.
- By analyzing behavioral signals, the platform achieves 86-88% accuracy in identifying individuals likely to experience
Read More
Circulate Health Secures Strategic Investment from Scrum Ventures to Scale TPE and Microplastics Removal Technology
What You Should Know:
- Circulate Health, a pioneer in Therapeutic Plasma Exchange (TPE) technologies, has secured a seven-figure strategic investment from Scrum Ventures.
- The funding will accelerate the company's growth as it works to position TPE as a scalable, patient-centered solution for longevity care. Circulate's platform leverages TPE to remove microplastics, environmental toxins, and inflammatory markers from the bloodstream, addressing the growing consumer demand
Read More
Curative Health Raises $150M, Reaches $1.275B Valuation to Disrupt Employer Health Insurance with AI and $0 Deductibles
What You Should Know:
- Curative Health Insurance Company, a health plan designed to replace the traditional insurance model, has raised over $150M in Series B funding, pushing its valuation to $1.275B and securing its unicorn status.
- The investment validates Curative's core offering: a $0-out-of-pocket plan that eliminates deductibles and copays for members who complete an annual preventative visit, driving a reported 30% reduction in hospitalizations.
- The capital
Read More
Voio Emerges from Stealth with $8.6M to Launch World’s Most Accurate Medical Imaging Model
What You Should Know:
Voio, a frontier AI lab spun out of UC Berkeley and UCSF, has secured $8.6M in seed funding led by Laude Ventures and The House Fund to launch a unified reading platformThe company's open-source model, Pillar-0, demonstrates unprecedented accuracy—outperforming leading models from Google and Microsoft by 10%–17% AUC—to address radiologist burnout and diagnostic delays.
Solving Fragmentation and Burnout in RadiologyVoio’s core mission is to solve the fragmentation that
Read More
